ArticleBMJ open2023

Amber photobiomodulation versus tranexamic acid for the treatment of melasma: protocol for a double-blind, randomised controlled trial.

Thais Rodrigues Galache et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.